Rankings
▼
Calendar
KMDA Q1 2025 Earnings — Kamada Ltd. Revenue & Financial Results | Market Cap Arena
KMDA
Kamada Ltd.
$520M
Q1 2025 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$44M
+16.6% YoY
Gross Profit
$21M
47.1% margin
Operating Income
$8M
17.7% margin
Net Income
$4M
9.0% margin
EPS (Diluted)
$0.07
QoQ Revenue Growth
+12.9%
Cash Flow
Operating Cash Flow
-$513,000
Free Cash Flow
-$2M
Stock-Based Comp.
$175,000
Balance Sheet
Total Assets
$375M
Total Liabilities
$123M
Stockholders' Equity
$252M
Cash & Equivalents
$76M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$44M
$38M
+16.6%
Gross Profit
$21M
$17M
+23.9%
Operating Income
$8M
$4M
+93.0%
Net Income
$4M
$2M
+67.6%
← Q4 2024
All Quarters
Q2 2025 →